FDA First Amendment Federal Register Notice Needs Clarification – Sen. Reed
This article was originally published in The Tan Sheet
Executive Summary
FDA should clarify the Federal Register notice in which it asks for comments on its application of the First Amendment by issuing a second notice and extending the comment deadline, Sen. Jack Reed (D-R.I.) says in a July 16 letter to the agency
You may also be interested in...
OTC Tax Deductibility Could Gain Favor In 108th Congress
CHPA believes the Republican majority in the Senate will be more willing to consider the association's proposal to make OTC drug purchases tax deductible
Supplement Claims Rules v. Drugs, Foods: FDA Opens Free Speech Debate
FDA invites public comments on the constitutionality of its approach to regulating claims for dietary supplements compared with Rx drugs and foods in a notice appearing in the May 16 Federal Register
Dietary supplement labels commission to be chaired by Cornell professor Nesheim.
DIETARY SUPPLEMENT COMMISSION TO BE CHAIRED BY CORNELL'S NESHEIM, the White House announced Oct. 2. Malden Nesheim, PhD, professor of nutrition at Cornell University, will head the seven-member commission established under the Dietary Supplement Health & Education Act of 1994 to generate recommendations for regulations and legislation related to label claims for dietary supplements.